Jump to content

User:MeredithGitre/Altogen Biosystems

From Wikipedia, the free encyclopedia
Altogen Biosystems
Company typePrivate
IndustryLife Science
Biotechnology
HeadquartersLas Vegas, Nevada, United States
ProductsTransfection reagents,
Websitewww.altogen.com

Altogen Biosystems is a life science company that specializes in manufacturing transfection reagents [1], with a focus on in vitro siRNA delivery and RNAi applications.[2][3]

Company Profile

[edit]

Altogen Biosystems began as a company focusing on non-viral methods of transfection. The company began to experiment with a variety of chemical reagents used to deliver nucleic acids into cells, and eventually started to optimize reagents for specific cell lines.[4] Currently, the company is investing into research pertaining to siRNA delivery and RNAi optimization in cell lines that are difficult to transfect.[5]

In 2017, Altogen Biosystems was named as one of the principal players in the transfection technology market by QY Research.[6]

Products

[edit]

Altogen Biosystems has developed an array of optimized transfection reagents [7], and offers custom life science research services at its GLP-compliant laboratory.[8] The company's transfection reagents are meant to help deliver compounds into cells through chemical means; reagents with lipids, nanoparticles, and PEGylated liposomes can allow compounds to enter a cell through the cell membrane.[9] The company also offers RNAi research services that optimize the conditions for RNA interference in chosen cell lines.[10]


References

[edit]
  1. ^ Macron, Doug (8 October 2009). "Reagent Shop Altogen Begins Looking to Apply Technologies to Therapeutic siRNA Delivery". Genomeweb. Retrieved 29 January 2018.
  2. ^ Blow, Nathan (13 December 2007). "Small RNAs: Delivering the future". Nature. 450: 1117–1120. doi:10.1038/4501117a.
  3. ^ "Preclinical Contract Research Studies". GHP Magazine: 14–15. February 2017.
  4. ^ Genetic Engineering and Biotechnology News: Volume 28, Issues 11-21. Gen Pub. 2008. p. 32.
  5. ^ Roberts, Josh P. (12 August 2014). "Primary Cells Pose No Problem with These Transfection Tools". BioCompare. Retrieved 29 January 2018.
  6. ^ Ghule, Ajinkya (9 October 2017). "Global Transfection Technologies Market 2017- Bio-Rad, Polyplus Transfection, MaxCyte". Retrieved 29 January 2018.
  7. ^ "New Products Focus: RNAi" (PDF). Science. 330 (6011): 1700. 17 December 2010. doi:10.1126/science.330.6011.1700-a.
  8. ^ "Pancreas-targeted siRNA In Vivo Transfection Kit from Altogen Biosystems". BioSpace. 6 March 2012. Retrieved 29 January 2018.
  9. ^ United States application US20150240262A1, Wenxin Wang & Abhay Pandit, "Polymer synthesis", assigned to National University of Ireland Galway 
  10. ^ Smith, Caitlin (23 February 2009). "siRNA Transfection Tools". BioCompare. Retrieved 29 January 2018.